For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

Barry Mook carries out research into bacterial meningitis, which continues to exact a heavy toll, even in developed countries. Around 80% of cases in Europe and the United States are caused by Streptococcus pneumoniae and Neisseria meningitis. Despite advances in medical care, mortality from pneumococcal meningitis ranges from 16 to 37%. Mook focuses on current understandings of the pathophysiology and pathogenic mechanisms associated with pneumococcal meningitis. He also discusses targets for future therapeutic strategies.

Event details of Treatment of bacterial meningitis
Date 2 December 2015
Time 12:00 -13:00
Location Agnietenkapel
Room Location

B.B. Mook: Translational Studies in Pneumococcal Meningitis.

Supervisor

Prof. D. van de Beek

Co-supervisor

Dr M.C. Brouwer

Agnietenkapel

Room Location

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam

Entrance

This event is open to the public.